MONSENSO A/S Company announcement no. 3-2021
The company's extraordinary general meeting was held today. At the meeting, the shareholders approved the following items in accordance with the proposal stated in the notice convening the extraordinary general meeting, ref. company announcement no. 2-2021:
- Proposal to expand the board from 4 to 5 members.
- Election of members to the Board of Directors.
Any inquiries regarding this notice should be directed to:
Monsenso:
Chairman of the board
Jukka P. Pertola
Mobile: +45 20 19 82 20
E-mail: jukka.pertola@pertola.com
CEO
Thomas Lethenborg
Mobile: +45 21 29 88 27
E-mail: lethenborg@monsenso.com
Certified Adviser:
Mobile: +45 20 72 02 00
E-mail: jn@nordencef.dk
About Monsenso
Monsenso is an innovative technology company offering mHealth solution that optimises the treatment of mental disorders. The smartphone-based solution gives a detailed overview of an individual’s mental health through the collection of outcome, adherence and behavioural data, and it connects individuals, carers and health care providers enabling personalised treatment, remote care and early intervention. Based on continued research and development, our team is committed to developing comprehensive solutions that fit seamlessly into the lives of individuals, increasing the quality and efficacy of their mental health and treatment. Our mission is to help individuals, carers, healthcare providers and researchers overcome the burden of mental illness. To learn more visit www.monsenso.com
Attachments
- Download announcement as PDF.pdf
© Ritzau Denmark, source
